| Dr George J Walker, MD | |
|
6020 E Arbor Ave, #101, Mesa, AZ 85206-6102 | |
| (480) 985-1700 | |
| (480) 396-3659 |
| Full Name | Dr George J Walker |
|---|---|
| Gender | Male |
| Speciality | Gastroenterology |
| Experience | 43 Years |
| Location | 6020 E Arbor Ave, Mesa, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528053121 | NPI | - | NPPES |
| 120390 | Other | AZ | GROUP MEDICARE NUMBER |
| 358839-02 | Medicaid | AZ | |
| 317047 | Other | AZ | GROUP MEDICAID NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0100X | Internal Medicine - Gastroenterology | 21847 (Arizona) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Banner Baywood Medical Center | Mesa, AZ | Hospital |
| Banner Heart Hospital | Mesa, AZ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Arizona Digestive Health Pc | 6507940731 | 79 |
News Archive
The U.S. Food and Drug Administration Agency (FDA) is still to make a desision on lung transplant treatment Pulminiq.
Using state-of-the-art robotic and x-ray crystallographic equipment, researchers at Saint Louis University have revealed for the first time the molecular structure of the zymogen, or inactive, form of a blood-clotting enzyme.
Pharmasset, Inc. announced today that dosing has begun in Part 2 of a Phase 1 study. This is the first clinical study combining a purine (PSI-938) and a pyrimidine (PSI-7977) nucleotide analog for HCV, and is designed to evaluate once daily doses of PSI-7977 and PSI-938 in patients with HCV who have not been treated previously.
Immune diseases like multiple sclerosis and hemophagocytic lymphohistiocytosis unleash destructive waves of inflammation on the body, causing death or a lifetime of illness and physical impairment.
› Verified 8 days ago
| Entity Name | Arizona Digestive Health Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1992981583 PECOS PAC ID: 6507940731 Enrollment ID: O20080227000334 |
News Archive
The U.S. Food and Drug Administration Agency (FDA) is still to make a desision on lung transplant treatment Pulminiq.
Using state-of-the-art robotic and x-ray crystallographic equipment, researchers at Saint Louis University have revealed for the first time the molecular structure of the zymogen, or inactive, form of a blood-clotting enzyme.
Pharmasset, Inc. announced today that dosing has begun in Part 2 of a Phase 1 study. This is the first clinical study combining a purine (PSI-938) and a pyrimidine (PSI-7977) nucleotide analog for HCV, and is designed to evaluate once daily doses of PSI-7977 and PSI-938 in patients with HCV who have not been treated previously.
Immune diseases like multiple sclerosis and hemophagocytic lymphohistiocytosis unleash destructive waves of inflammation on the body, causing death or a lifetime of illness and physical impairment.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr George J Walker, MD 3020 E Camelback Rd, Suite 301, Phoenix, AZ 85014-5095 Ph: (602) 264-9100 | Dr George J Walker, MD 6020 E Arbor Ave, #101, Mesa, AZ 85206-6102 Ph: (480) 985-1700 |
News Archive
The U.S. Food and Drug Administration Agency (FDA) is still to make a desision on lung transplant treatment Pulminiq.
Using state-of-the-art robotic and x-ray crystallographic equipment, researchers at Saint Louis University have revealed for the first time the molecular structure of the zymogen, or inactive, form of a blood-clotting enzyme.
Pharmasset, Inc. announced today that dosing has begun in Part 2 of a Phase 1 study. This is the first clinical study combining a purine (PSI-938) and a pyrimidine (PSI-7977) nucleotide analog for HCV, and is designed to evaluate once daily doses of PSI-7977 and PSI-938 in patients with HCV who have not been treated previously.
Immune diseases like multiple sclerosis and hemophagocytic lymphohistiocytosis unleash destructive waves of inflammation on the body, causing death or a lifetime of illness and physical impairment.
› Verified 8 days ago
Dr. Emmanuel A Bayongan, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1400 S Dobson Rd, Mesa, AZ 85202 Phone: 480-543-2034 Fax: 480-512-6089 | |
Dr. Sanjeev Gopal, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 6424 E Broadway Rd, 104-105, Mesa, AZ 85206 Phone: 602-802-8700 Fax: 602-802-8799 | |
Mouhsen H Alhakeem, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 1400 S Dobson Road, Attn Amanda Gump/hospitalist, Mesa, AZ 85202 Phone: 480-412-6788 Fax: 480-412-6848 | |
Dr. Bindu Jayavelu, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 301 S Power Rd Ste 103, Mesa, AZ 85206 Phone: 480-325-7535 Fax: 480-325-7462 | |
Mr. Robert Bobek Arashahi, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 5652 E Baseline Rd, Mesa, AZ 85206 Phone: 480-477-7166 | |
Mr. Robert P Tully, M.D. Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 7525 E Broadway Rd, Ste 2, Mesa, AZ 85208 Phone: 480-981-9800 Fax: 480-985-9465 | |
Joshua D Cohen, MD Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 6750 E Baywood Ave, 301, Mesa, AZ 85206 Phone: 480-835-6100 Fax: 480-461-4261 |